Literature DB >> 18927140

Costs and cost-effectiveness of family CBT versus individual CBT in clinically anxious children.

Denise H M Bodden1, Carmen D Dirksen, Susan M Bögels, Maaike H Nauta, Else De Haan, Jaap Ringrose, Carla Appelboom, Andries G Brinkman, Karen C M M J Appelboom-Geerts.   

Abstract

The objective of this study was to investigate the cost-effectiveness of family cognitive-behavioral therapy (CBT) compared with individual CBT in children with anxiety disorders. Clinically anxious children (aged 8-18 years) referred for treatment were randomly assigned to family or individual CBT and were assessed pre-treatment, post treatment, and at 3 months and 1 year after treatment. Cost-effectiveness ratios were calculated expressing the incremental costs per anxiety-free child and the incremental costs per Quality Adjusted Life Year (QALY) for the referred child. Neither societal costs nor effectiveness were significantly different between individual and family CBT. However, the point estimates of the cost-effectiveness ratios resulted in dominance for individual CBT, indicating that individual CBT is more effective and less costly than family CBT. These results were confirmed by bootstrap analyses and cost-effectiveness acceptability curves. Several secondary and sensitivity analyses showed that the results were robust. It can be concluded that family CBT is not a cost-effective treatment for clinically anxious children, compared with individual CBT.

Entities:  

Mesh:

Year:  2008        PMID: 18927140     DOI: 10.1177/1359104508090602

Source DB:  PubMed          Journal:  Clin Child Psychol Psychiatry        ISSN: 1359-1045            Impact factor:   2.544


  17 in total

1.  Parental Health Spillover in Cost-Effectiveness Analysis: Evidence from Self-Harming Adolescents in England.

Authors:  Sandy Tubeuf; Eirini-Christina Saloniki; David Cottrell
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

2.  An explorative cost-effectiveness analysis of school-based screening for child anxiety using a decision analytic model.

Authors:  Ellin Simon; Carmen D Dirksen; Susan M Bögels
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-03-29       Impact factor: 4.785

Review 3.  The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.

Authors:  Michael Sonntag; Hans-Helmut König; Alexander Konnopka
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

4.  Cognitive behavioural therapy for anxiety disorders in children and adolescents.

Authors:  Anthony C James; Tessa Reardon; Angela Soler; Georgina James; Cathy Creswell
Journal:  Cochrane Database Syst Rev       Date:  2020-11-16

5.  A cost of illness study of children with high-functioning autism spectrum disorders and comorbid anxiety disorders as compared to clinically anxious and typically developing children.

Authors:  Francisca J A van Steensel; Carmen D Dirksen; Susan M Bögels
Journal:  J Autism Dev Disord       Date:  2013-12

6.  Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis.

Authors:  Francisca J A van Steensel; Susan M Bögels; Sean Perrin
Journal:  Clin Child Fam Psychol Rev       Date:  2011-09

7.  The validity of the Child Health Utility instrument (CHU9D) as a routine outcome measure for use in child and adolescent mental health services.

Authors:  Gareth Furber; Leonie Segal
Journal:  Health Qual Life Outcomes       Date:  2015-02-18       Impact factor: 3.186

8.  Measuring Health Utilities in Children and Adolescents: A Systematic Review of the Literature.

Authors:  Dominic Thorrington; Ken Eames
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 9.  Family treatment of child anxiety: outcomes, limitations and future directions.

Authors:  Cathy Creswell; Sam Cartwright-Hatton
Journal:  Clin Child Fam Psychol Rev       Date:  2007-09

10.  Do Costs in the Education Sector Matter? A Systematic Literature Review of the Economic Impact of Psychosocial Problems on the Education Sector.

Authors:  Irina Pokhilenko; Luca M M Janssen; Silvia M A A Evers; Ruben M W A Drost; Lena Schnitzler; Aggie T G Paulus
Journal:  Pharmacoeconomics       Date:  2021-06-14       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.